U.S. flag

An official website of the United States government

NM_001308093.3(GATA4):c.620A>G (p.Asp207Gly) AND Tetralogy of Fallot

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 24, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004598508.1

Allele description [Variation Report for NM_001308093.3(GATA4):c.620A>G (p.Asp207Gly)]

NM_001308093.3(GATA4):c.620A>G (p.Asp207Gly)

Gene:
GATA4:GATA binding protein 4 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
8p23.1
Genomic location:
Preferred name:
NM_001308093.3(GATA4):c.620A>G (p.Asp207Gly)
HGVS:
  • NC_000008.11:g.11748919A>G
  • NG_008177.2:g.77001A>G
  • NM_001308093.3:c.620A>GMANE SELECT
  • NM_001308094.2:c.-2A>G
  • NM_001374273.1:c.-2A>G
  • NM_001374274.1:c.-2A>G
  • NM_002052.5:c.617A>G
  • NP_001295022.1:p.Asp207Gly
  • NP_002043.2:p.Asp206Gly
  • NC_000008.10:g.11606428A>G
Protein change:
D206G
Molecular consequence:
  • NM_001308094.2:c.-2A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001374273.1:c.-2A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001374274.1:c.-2A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001308093.3:c.620A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002052.5:c.617A>G - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Tetralogy of Fallot (TOF)
Synonyms:
Fallot tetralogy
Identifiers:
MONDO: MONDO:0008542; MedGen: C0039685; Orphanet: 3303; OMIM: 187500; Human Phenotype Ontology: HP:0001636

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV005091917MVZ Medizinische Genetik Mainz
criteria provided, single submitter

(UK Practice Guidelines For Variant Classification V4 01 2020)
Uncertain significance
(May 24, 2024)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot providednot providednot providedclinical testing

Details of each submission

From MVZ Medizinische Genetik Mainz, SCV005091917.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

ACMG Criteria: PM2_SUP,PP3

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Aug 11, 2024